Glutaminase inhibition in combination with azacytidine in myelodysplastic syndromes: a phase 1b/2 clinical trial and correlative analyses.
Britta Will, Steven Grant, Kith Pradhan, Srinivas Aluri, G Lavender Hackman, Natalia Baran, Naval G Daver, Kiran Naqvi, Alessia Lodi, Michael R Green, Ulrich Steidl, Beamon Agarwal, Jan Burger, Nicholas J Short, Tushar D Bhagat, Amit Verma, Xiaoping Su, Steven Kornblau, Tapan Kadia, Qing Deng, Stefano Tiziani, Divij Verma, Gautam Borthakur, Elias Jabbour, Courtney D DiNardo, Naveen Pemmaraju, Marina Konopleva, Guillermo Garcia-Manero, Anna Skwarska, Kapil Saxena, Tianyu Cai, Veronica A Guerra, Gowri Poigaialwar, Vinitha M Kuruvilla, Sergej Konoplev, Shanisha Gordon-Mitchell, Sovira Chaudhry, Meghan Collins, Shannon R Sweeney, Jonathan Busquets, Atul Singh Rathore, Susan Demo, Gaurav S Choudhary, Srabani Sahu, Mason Spodek, Victor Thiruthuvanathan, George D Tippett
Nature cancer 2024;5(10):1515-1533